Unknown NA INTERVENTIONAL NCT01930903

PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon (PaneLux PTCA)

Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon

Sponsor: Biotronik France

Conditions Coronary Artery Disease High Bleeding Risk Patients

Interventions Pantera Lux Drug Eluting Balloon

Updated 5 times since 2017 Last updated: Apr 29, 2015 Started: Sep 30, 2013 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Coronary Artery Disease and High Bleeding Risk Patients, this trial is ongoing. The trial is conducted by Biotronik France and has accumulated 5 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biotronik France
MedPass International

Data source: Biotronik France

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toulouse, France